Pazzaglia C - Search Results

1

Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease.

Bertini A, Manganelli F, Fabrizi GM, Schenone A, Santoro L, Cavallaro T, Tagliapietra M, Grandis M, Previtali SC, Falzone YM, Allegri I, Padua L, Pazzaglia C, Tramacere I, Cavalca E, Saveri P, Quattrone A, Valentino P, Tozza S, Gentile L, Russo M, Mazzeo A, Vita G, Prada V, Zuccarino R, Ferraro F, Pisciotta C, Pareyson D; Italian CMT Network. Bertini A, et al. Among authors: pazzaglia c. J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):434-441. doi: 10.1136/jnnp-2023-332422. J Neurol Neurosurg Psychiatry. 2024. PMID: 37918904 Free PMC article.

2

Initial characterization of an anti-CD5 monoclonal antibody obtained from leukemic cells infiltrating lymphocytes.

Delfini C, Centis F, Muretto P, Staccioli MP, Pazzaglia C. Delfini C, et al. Among authors: pazzaglia c. Haematologica. 1993 May-Jun;78(3):145-50. Haematologica. 1993. PMID: 7690732

3

Work increases the incidence of carpal tunnel syndrome in the general population.

Pazzaglia C, Caliandro P, Pauda L. Pazzaglia C, et al. Muscle Nerve. 2008 Oct;38(4):1345-6; author reply 1346. Muscle Nerve. 2008. PMID: 18938266 Free article. No abstract available.

4

Brain-evoked potentials as a tool for diagnosing neuropathic pain.

Pazzaglia C, Valeriani M. Pazzaglia C, et al. Expert Rev Neurother. 2009 May;9(5):759-71. doi: 10.1586/ern.09.16. Expert Rev Neurother. 2009. PMID: 19402783 Review.

5

Habituation to pain in "medication overuse headache": a CO2 laser-evoked potential study.

Ferraro D, Vollono C, Miliucci R, Virdis D, De Armas L, Pazzaglia C, Le Pera D, Tarantino S, Balestri M, Di Trapani G, Valeriani M. Ferraro D, et al. Among authors: pazzaglia c. Headache. 2012 May;52(5):792-807. doi: 10.1111/j.1526-4610.2012.02151.x. Epub 2012 Apr 18. Headache. 2012. PMID: 22512411

6

Laser evoked potential amplitude and laser-pain rating reduction during high-frequency non-noxious somatosensory stimulation.

Valeriani M, Pazzaglia C, Rizzo V, Quartarone A, Vollono C. Valeriani M, et al. Among authors: pazzaglia c. Clin Neurophysiol. 2018 May;129(5):920-925. doi: 10.1016/j.clinph.2018.02.004. Epub 2018 Feb 24. Clin Neurophysiol. 2018. PMID: 29550652

7

Malignant melanoma of the glans penis in a chronic myeloid leukemia patient after busulfan therapy.

Sparaventi G, Manna A, Muretto P, Pazzaglia C, Palazzi M, Porcellini A. Sparaventi G, et al. Among authors: pazzaglia c. Tumori. 1987 Dec 31;73(6):645-8. doi: 10.1177/030089168707300617. Tumori. 1987. PMID: 3481141

8

Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life.

Padua L, Sabatelli M, Evoli A, Pazzaglia C, Tonali P. Padua L, et al. Among authors: pazzaglia c. Hum Immunol. 2005 Apr;66(4):417-21. doi: 10.1016/j.humimm.2005.01.023. Hum Immunol. 2005. PMID: 15866706 Review.

9

Quality of life is not impaired in patients with hereditary neuropathy with liability to pressure palsies.

Padua L, Pazzaglia C, Cavallaro T, Commodari I, Pareyson D, Quattrone A, Rizzuto N, Vita G, Tonali PA, Schenone A; Italian CMT QoL Study Group. Padua L, et al. Among authors: pazzaglia c. Eur J Neurol. 2007 Jan;14(1):e45-6. doi: 10.1111/j.1468-1331.2006.01545.x. Eur J Neurol. 2007. PMID: 17222096 No abstract available.

10

Reliability of clinical outcome measures in Charcot-Marie-Tooth disease.

Solari A, Laurà M, Salsano E, Radice D, Pareyson D; CMT-TRIAAL Study Group. Solari A, et al. Neuromuscul Disord. 2008 Jan;18(1):19-26. doi: 10.1016/j.nmd.2007.09.006. Epub 2007 Oct 26. Neuromuscul Disord. 2008. PMID: 17964785 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters